Caris Molecular Intelligence is a broad-based molecular profiling service to support the identification of potential biomarkers associated with targeted therapies for cancer care. LINK was the first company to introduce this technology to the UK, established an international Expert Panel to support clinicians and their patient treatment plans, and gained a positive NICE statement and PMI reimbursement for the private sector, becoming Caris’ top international distributor with significant growth year on year.
